Park National Corporation
AMEX:PRKBanks - Regional
+$2.44 today
- Market cap
- $3.09B
- Beta
- 0.70
- P/E (TTM)
- 17.0
- EPS (TTM)
- $10.33
- Dividend yield
- 3.18%
Volume 0.07M
Average 0.09M
PRK Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Park National CorporationAMEX: PRK
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How PRK compares with its peers on the latest reported figures
- PRK's LTM Sep 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for PRK, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding PRK) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for PRK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 475.8M | 514.18M | 564.3M | 645.55M | 664.42M |
| Cost of Revenue | 4.04M | 35.75M | 101.46M | 139.49M | 118.72M |
| Gross Profit | 471.75M | 478.44M | 462.84M | 506.06M | 545.7M |
| Gross Margin | 99.2% | 93.0% | 82.0% | 78.4% | 82.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 179.18M | 184.54M | 194.61M | 202.09M | 207.6M |
| Operating Expenses | 283.52M | 297.98M | 309.24M | 321.34M | 324.38M |
| Depreciation & Amortization | 13.27M | 13.82M | 14.02M | 12.19M | 11.19M |
| EBITDA | 201.5M | 194.28M | 167.62M | 196.92M | 232.51M |
| EBITDA Margin | 42.4% | 37.8% | 29.7% | 30.5% | 35.0% |
| Operating Income | 188.24M | 180.46M | 153.6M | 184.73M | 221.32M |
| Operating Margin | 39.6% | 35.1% | 27.2% | 28.6% | 33.3% |
| Interest Income | 345.85M | 378.25M | 471.67M | 522.97M | 544.54M |
| Interest Expense | 15.96M | 31.19M | 98.56M | 124.95M | 107.23M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 188.24M | 180.46M | 153.6M | 184.73M | 221.32M |
| Pre-Tax Margin | 39.6% | 35.1% | 27.2% | 28.6% | 33.3% |
| Income Tax Expense | 34.29M | 32.11M | 26.87M | 33.31M | 41.25M |
| Net Income | 153.95M | 148.35M | 126.73M | 151.42M | 180.07M |
| Net Margin | 32.4% | 28.9% | 22.5% | 23.5% | 27.1% |
| EPS (Basic) | 9.45 | 9.13 | 7.84 | 9.38 | 11.18 |
| EPS (Diluted) | 9.37 | 9.07 | 7.80 | 9.32 | 11.11 |
| Weighted Avg Shares | 16.29M | 16.25M | 16.16M | 16.14M | 16.08M |
| Weighted Avg Shares (Diluted) | 16.43M | 16.37M | 16.25M | 16.25M | 16.18M |
Park National Corporation
AMEX:PRK
Intrinsic Alpha fair value
Locked
Current Price
$171.12
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.